QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
NASDAQ:BBH

VanEck Biotech ETF (BBH) Price, Holdings, & News

$162.74
-3.20 (-1.93%)
(As of 02/29/2024 ET)
Today's Range
$162.74
$166.72
50-Day Range
$158.48
$170.60
52-Week Range
$142.51
$171.04
Volume
7,641 shs
Average Volume
9,779 shs
Market Capitalization
$450.79 million
Assets Under Management
$460.03 million
Dividend Yield
0.44%
Net Expense Ratio
0.35%
BBH stock logo

About VanEck Biotech ETF (NASDAQ:BBH)

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.

BBH Stock Price History

BBH ETF News Headlines

Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
BBH: A Solid Way To Play A Comeback In Biotech
BBH ETF Stock Price History
VanEck ETFs
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Van Eck Biotech Etf $BBH Trading Report
See More Headlines
Receive BBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Van Eck
Fund Name
VanEck Biotech ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:BBH
Inception Date
12/20/2011
Fund Manager
Hao-Hung Peter Liao, Guo Hua Jason Jin
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Market Vectors US Listed Biotech 25 Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
Global
Number of Holdings
24

Fund Statistics

Assets Under Management
$460.03 million
Average Daily Volume
$667.70
Discount/Premium
-0.05%

Administrator, Advisor and Custodian

Administrator
Van Eck Associates Corporation
Advisor
Van Eck Associates Corporation
Custodian
State Street Bank and Trust Company
Distributor
Van Eck Securities Corporation
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
N/A
Short Interest
700 shs

Miscellaneous

Beta
0.75
Creation Unit
50,000
Creation Fee
$500.00
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

VanEck Biotech ETF Expenses

TypeBBHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.35%0.57%0.54%0.47%0.51%
Other Expenses0.00%0.40%0.55%0.33%0.58%
Total Expense0.35%0.72%0.70%0.57%0.70%
Fee Waiver0.00%-0.53%-0.55%-0.20%-0.57%
Net Expense0.35%0.61%0.60%0.53%0.58%

VanEck Biotech ETF (BBH) Holdings & Exposure















BBH ETF - Frequently Asked Questions

How have BBH shares performed in 2024?

VanEck Biotech ETF's stock was trading at $165.31 at the start of the year. Since then, BBH stock has decreased by 1.6% and is now trading at $162.74.
View the best growth stocks for 2024 here
.

Are investors shorting VanEck Biotech ETF?

VanEck Biotech ETF saw a decline in short interest during the month of February. As of February 15th, there was short interest totaling 700 shares, a decline of 22.2% from the January 31st total of 900 shares. Based on an average daily trading volume, of 12,700 shares, the short-interest ratio is presently 0.1 days.
View VanEck Biotech ETF's Short Interest
.

How often does VanEck Biotech ETF pay dividends? What is the dividend yield for VanEck Biotech ETF?

VanEck Biotech ETF declared an annual dividend on Friday, December 15th. Investors of record on Tuesday, December 19th will be given a dividend of $0.7127 per share on Friday, December 22nd. The ex-dividend date is Monday, December 18th.
Read our dividend analysis for BBH
.

What does BBH invest in?

VanEck Biotech ETF is a equity fund issued by Van Eck. BBH focuses on health care investments and follows the Market Vectors US Listed Biotech 25 Index. The fund's investments total to approximately $460.03 million assets under management.

What stocks does VanEck Biotech ETF hold?
What is the management fee for VanEck Biotech ETF?

VanEck Biotech ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for BBH is 0.35%.

What other stocks do shareholders of VanEck Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Biotech ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Intel (INTC), Micron Technology (MU), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), Novavax (NVAX).

Who are VanEck Biotech ETF's major shareholders?

VanEck Biotech ETF's stock is owned by many different institutional and retail investors. Top institutional investors include Goldman Sachs Group Inc. (4.00%), Miller Investment Management LP (3.64%), Royal Bank of Canada (0.94%), UBS Group AG (0.85%), Envestnet Asset Management Inc. (0.72%) and Conservest Capital Advisors Inc. (0.70%).

How do I buy shares of VanEck Biotech ETF?

Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BBH) was last updated on 2/29/2024 by MarketBeat.com Staff